Citadel Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $129M | Sell |
2,681,069
-2,592,796
| -49% | -$114M | 0.09% | 661 |
|
|
2025
Q4 | $204M | Buy |
5,273,865
+4,879,192
| +1,236% | +$186M | 0.14% | 480 |
|
|
2025
Q3 | $13.9M | Sell |
394,673
-132,615
| -25% | -$4.8M | 0.01% | 2777 |
|
|
2025
Q2 | $19M | Sell |
527,288
-1,538,488
| -74% | -$51M | 0.02% | 2208 |
|
|
2025
Q1 | $64.3M | Sell |
2,065,776
-832,188
| -29% | -$26.4M | 0.06% | 963 |
|
|
2024
Q4 | $73.9M | Buy |
+2,897,964
| New | +$76.8M | 0.07% | 951 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 15226 |
|
|
2024
Q2 | – | Sell |
-97,919
| Closed | -$2.71M | – | 15303 |
|
|
2024
Q1 | $2.97M | Sell |
97,919
-389,101
| -80% | -$11.5M | ﹤0.01% | 4807 |
|
|
2023
Q4 | $13.7M | Buy |
487,020
+363,939
| +296% | +$10M | 0.01% | 2448 |
|
|
2023
Q3 | $3.34M | Sell |
123,081
-532,291
| -81% | -$15.8M | ﹤0.01% | 4297 |
|
|
2023
Q2 | $20.1M | Sell |
655,372
-423,582
| -39% | -$14.3M | 0.02% | 1877 |
|
|
2023
Q1 | $38.9M | Buy |
1,078,954
+567,014
| +111% | +$21M | 0.04% | 1302 |
|
|
2022
Q4 | $20.2M | Buy |
511,940
+175,979
| +52% | +$7.35M | 0.02% | 1952 |
|
|
2022
Q3 | $13.5M | Buy |
335,961
+76,116
| +29% | +$3.25M | 0.02% | 2355 |
|
|
2022
Q2 | $10.9M | Sell |
259,845
-1,323,288
| -84% | -$54.2M | 0.01% | 2572 |
|
|
2022
Q1 | $61.7M | Buy |
1,583,133
+1,371,252
| +647% | +$53.8M | 0.07% | 969 |
|
|
2021
Q4 | $8.44M | Buy |
211,881
+99,702
| +89% | +$3.87M | 0.01% | 3351 |
|
|
2021
Q3 | $4.05M | Sell |
112,179
-377,172
| -77% | -$14.7M | ﹤0.01% | 4718 |
|
|
2021
Q2 | $20.1M | Buy |
489,351
+351,746
| +256% | +$15M | 0.02% | 2081 |
|
|
2021
Q1 | $6M | Sell |
137,605
-186,636
| -58% | -$8.85M | 0.01% | 3867 |
|
|
2020
Q4 | $16.2M | Buy |
324,241
+256,692
| +380% | +$10.9M | 0.02% | 2037 |
|
|
2020
Q3 | $2.84M | Sell |
67,549
-856,056
| -93% | -$36.7M | ﹤0.01% | 4075 |
|
|
2020
Q2 | $44.8M | Buy |
+923,605
| New | +$45.7M | 0.06% | 869 |
|
Other funds holding RPRX
